Search Results | Cancer Research | American Association for Cancer Research

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Abstract 699: NF-kB is a master regulator of resistance to therapy in high-risk neuroblastoma

Cancer Res (2022) 82 (12_Supplement): 699.

DOI: https://doi.org/10.1158/1538-7445.AM2022-699

Published: 15 June 2022

View article

Journal Articles

Abstract 6051: Longitudinal single-cell sequencing of high-risk neuroblastoma tumors reveals intrinsic and extrinsic mechanisms of therapy resistance

Cancer Res (2022) 82 (12_Supplement): 6051.

DOI: https://doi.org/10.1158/1538-7445.AM2022-6051

Published: 15 June 2022

View article

Journal Articles

Low Glucose–Induced Overexpression of HOXC-AS3 Promotes Metabolic Reprogramming of Breast Cancer

Wenjie Zhu, Xu Chen, Xiangyu Guo, Haiting Liu, Ranran Ma, Yawen Wang, Yahang Liang, Ying Sun, Mengqi Wang, Ruinan Zhao, Peng Gao

Cancer Res (2022) 82 (5): 805–818.

DOI: https://doi.org/10.1158/0008-5472.CAN-21-1179

Published: 03 March 2022

View article

Includes: Supplementary data

Journal Articles

EGR1-Mediated Transcription of lncRNA-HNF1A-AS1 Promotes Cell-Cycle Progression in Gastric Cancer

Hai-Ting Liu, Sen Liu, Lei Liu, Ran-Ran Ma, Peng Gao

Cancer Res (2018) 78 (20): 5877–5890.

DOI: https://doi.org/10.1158/0008-5472.CAN-18-1011

Published: 15 October 2018

View article

Includes: Supplementary data

Journal Articles

NK Cells Mediate Synergistic Antitumor Effects of Combined Inhibition of HDAC6 and BET in a SCLC Preclinical Model

Yan Liu, Yuyang Li, Shengwu Liu, Dennis O. Adeegbe, Camilla L. Christensen, Max M. Quinn, Ruben Dries, Shiwei Han, Kevin Buczkowski, Xiaoen Wang, Ting Chen, Peng Gao, Hua Zhang, Fei Li, Peter S. Hammerman, James E. Bradner, Steven N. Quayle, Kwok-Kin Wong

Cancer Res (2018) 78 (13): 3709–3717.

DOI: https://doi.org/10.1158/0008-5472.CAN-18-0161

Published: 01 July 2018

View article

Includes: Supplementary data

Journal Articles

Abstract 2280: Systematic analysis of causal noncoding mutations in pediatric B-cell acute lymphoblastic leukemia

Bing He, Peng Gao, Yang Ding, Chia-Hui Chen, Hannah Kim, Stephen P. Hunger, Sarah K. Tasian, Kai Tan

Cancer Res (2018) 78 (13_Supplement): 2280.

DOI: https://doi.org/10.1158/1538-7445.AM2018-2280

Published: 01 July 2018

View article

Journal Articles

Gemcitabine and Chk1 Inhibitor AZD7762 Synergistically Suppress the Growth of Lkb1-Deficient Lung Adenocarcinoma

Yan Liu, Yuyang Li, Xiaoen Wang, Feiyang Liu, Peng Gao, Max M. Quinn, Fei Li, Ashley A. Merlino, Cyril Benes, Qingsong Liu, Nathanael S. Gray, Kwok-Kin Wong

Cancer Res (2017) 77 (18): 5068–5076.

DOI: https://doi.org/10.1158/0008-5472.CAN-17-0567

Published: 14 September 2017

View article

Includes: Supplementary data

Journal Articles

Abstract 4619: CD47 promotes ovarian cancer progression by inhibiting macrophage phagocytosis

Yuting Huang, Peng Gao, Yifeng He, Yuchi Ma, Shangwen Dong, Zhijun Li

Cancer Res (2017) 77 (13_Supplement): 4619.

DOI: https://doi.org/10.1158/1538-7445.AM2017-4619

Published: 01 July 2017

View article

Journal Articles

Abstract 5642: Quantitative comparison of hydrocortisone and prednisone in the postoperative hormone therapy of hypercortisolism

Kunlong Tang, Yuting Huang, Shangwen Dong, Peng Gao

Cancer Res (2017) 77 (13_Supplement): 5642.

DOI: https://doi.org/10.1158/1538-7445.AM2017-5642

Published: 01 July 2017

View article

Journal Articles

Abstract 1474: Epigenetic silencing of microRNA-137 enhances ASCT2 expression and tumor glutamine metabolism

Xiao Daibiao, Junli Dong, Zihan Zhao, Ping Ren, Cong Li, Yufeng Hu, Jianguo Shi, Hexiu Su, Zhaojing Wang, Hudan Liu, Bo Li, Peng Gao, Guoliang Qing

Cancer Res (2017) 77 (13_Supplement): 1474.

DOI: https://doi.org/10.1158/1538-7445.AM2017-1474

Published: 01 July 2017

View article

Journal Articles

Abstract 3063: Discovery of a third-generation EGFR inhibitor, which is highly selective and potent against both resistant and activating EGFR mutations for NSCLC therapy

Rudi Bao, Peng Gao, Fujun Zhang, Zhaolong Tong, Hongping Yu, Yaochang Xu

Cancer Res (2016) 76 (14_Supplement): 3063.

DOI: https://doi.org/10.1158/1538-7445.AM2016-3063

Published: 15 July 2016

View article

Journal Articles

STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment

Cancer Res (2016) 76 (5): 999–1008.

DOI: https://doi.org/10.1158/0008-5472.CAN-15-1439

Published: 29 February 2016

View article

Includes: Supplementary data

Journal Articles

Metabolic Characterization of Hepatocellular Carcinoma Using Nontargeted Tissue Metabolomics

Qiang Huang, Yexiong Tan, Peiyuan Yin, Guozhu Ye, Peng Gao, Xin Lu, Hongyang Wang, Guowang Xu

Cancer Res (2013) 73 (16): 4992–5002.

DOI: https://doi.org/10.1158/0008-5472.CAN-13-0308

Published: 13 August 2013

View article

Includes: Supplementary data

Journal Articles

RXRα Inhibits the NRF2-ARE Signaling Pathway through a Direct Interaction with the Neh7 Domain of NRF2

Hongyan Wang, Kaihua Liu, Miao Geng, Peng Gao, Xiaoyuan Wu, Yan Hai, Yangxia Li, Yulong Li, Lin Luo, John D. Hayes, Xiu Jun Wang, Xiuwen Tang

Cancer Res (2013) 73 (10): 3097–3108.

DOI: https://doi.org/10.1158/0008-5472.CAN-12-3386

Published: 12 May 2013

View article

Includes: Supplementary data

Journal Articles

Characterization of Torin2, an ATP-Competitive Inhibitor of mTOR, ATM, and ATR

Cancer Res (2013) 73 (8): 2574–2586.

DOI: https://doi.org/10.1158/0008-5472.CAN-12-1702

Published: 15 April 2013

View article

Includes: Supplementary data

Journal Articles

Abstract 838A: Characterization of sphingosine kinase isoenzyme selective inhibitors

Peng Gao, Yan Zhuang, Charles D. Smith

Cancer Res (2010) 70 (8_Supplement): 838A.

DOI: https://doi.org/10.1158/1538-7445.AM10-838A

Published: 15 April 2010

View article

Journal Articles

Functional comparison of sphingosine kinase isozymes in A498 kidney carcinoma cells

Peng Gao, Charles Smith

Cancer Res (2008) 68 (9_Supplement): 2375.

Published: 01 May 2008

View article

NARROW

Abstract 699: NF-kB is a master regulator of resistance to therapy in high-risk neuroblastoma

Abstract 6051: Longitudinal single-cell sequencing of high-risk neuroblastoma tumors reveals intrinsic and extrinsic mechanisms of therapy resistance

Low Glucose–Induced Overexpression of HOXC-AS3 Promotes Metabolic Reprogramming of Breast Cancer

EGR1-Mediated Transcription of lncRNA-HNF1A-AS1 Promotes Cell-Cycle Progression in Gastric Cancer

NK Cells Mediate Synergistic Antitumor Effects of Combined Inhibition of HDAC6 and BET in a SCLC Preclinical Model

Abstract 2280: Systematic analysis of causal noncoding mutations in pediatric B-cell acute lymphoblastic leukemia

Gemcitabine and Chk1 Inhibitor AZD7762 Synergistically Suppress the Growth of Lkb1-Deficient Lung Adenocarcinoma

Abstract 4619: CD47 promotes ovarian cancer progression by inhibiting macrophage phagocytosis

Abstract 5642: Quantitative comparison of hydrocortisone and prednisone in the postoperative hormone therapy of hypercortisolism

Abstract 1474: Epigenetic silencing of microRNA-137 enhances ASCT2 expression and tumor glutamine metabolism

Abstract 3063: Discovery of a third-generation EGFR inhibitor, which is highly selective and potent against both resistant and activating EGFR mutations for NSCLC therapy

STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment

Metabolic Characterization of Hepatocellular Carcinoma Using Nontargeted Tissue Metabolomics

RXRα Inhibits the NRF2-ARE Signaling Pathway through a Direct Interaction with the Neh7 Domain of NRF2

Characterization of Torin2, an ATP-Competitive Inhibitor of mTOR, ATM, and ATR

Abstract 838A: Characterization of sphingosine kinase isoenzyme selective inhibitors

Functional comparison of sphingosine kinase isozymes in A498 kidney carcinoma cells

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only